Cargando…

Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study

BACKGROUND: Combined with cancer screening programs, vaccination against human papillomavirus (HPV) can significantly reduce the high health and economic burden of HPV-related disease in Japan. The objective of this study was to assess the health impact and cost effectiveness of routine and catch-up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cody, Palmer, Tobe, Keisuke, Abe, Machiko, Elbasha, Elamin H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789539/ https://www.ncbi.nlm.nih.gov/pubmed/33407188 http://dx.doi.org/10.1186/s12879-020-05632-0

Ejemplares similares

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
por: Daniels, Vincent, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population
por: Huang, Min, et al.
Publicado: (2023)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
por: Boiron, L., et al.
Publicado: (2016)

Intentions for catch-up HPV vaccination in Japan: an internet survey
por: Nakagawa, Satoshi, et al.
Publicado: (2023)

Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations
por: Watanabe, Yuko, et al.
Publicado: (2023)

1737. Cost-Effectiveness Analysis of Catch-Up Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Spotlight on the 9-valent HPV vaccine
por: Lopalco, Pier Luigi
Publicado: (2016)

Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
por: Paz-Zulueta, María, et al.
Publicado: (2018)

Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
por: Yagi, Asami, et al.
Publicado: (2022)

Vaccination and herd immunity thresholds in heterogeneous populations
por: Elbasha, Elamin H., et al.
Publicado: (2021)

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2023)

Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles
por: Banura, Cecily, et al.
Publicado: (2012)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
por: Serrano, Beatriz, et al.
Publicado: (2012)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines
por: Hartwig, Susanne, et al.
Publicado: (2015)

The potential cost-effectiveness of HPV vaccination among girls in Mongolia
por: Luvsan, Munkh-Erdene, et al.
Publicado: (2022)

Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
por: Kiatpongsan, Sorapop, et al.
Publicado: (2014)

Is the catch‐up program of HPV vaccination for Japanese adult women effective or not?
por: Kurokawa, Tetsuji
Publicado: (2020)

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
por: Insinga, Ralph P, et al.
Publicado: (2009)

Model for Assessing Human Papillomavirus Vaccination Strategies
por: Elbasha, Elamin H., et al.
Publicado: (2007)

Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
por: Hayajneh, Wail A., et al.
Publicado: (2018)

Easy access to vaccination was important for adherence during the 2016–2019 HPV catch-up vaccination in Norway
por: van Boetzelaer, E., et al.
Publicado: (2021)

Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
por: Satomura, Kazunari, et al.
Publicado: (2014)

Flu vaccine associated with nine deaths in Japan this year
Publicado: (2013)

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
por: Kind, André B., et al.
Publicado: (2020)

Correction to: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
por: Hayajneh, Wail A., et al.
Publicado: (2019)

Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?
por: Bonanni, Paolo, et al.
Publicado: (2015)

Japan’s Ongoing Crisis on HPV Vaccination
por: Sekine, Masayuki, et al.
Publicado: (2020)

Changing trends in HPV vaccination in Japan
por: Ujiie, Mugen, et al.
Publicado: (2021)

Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
por: Min, Kyung-Jin, et al.
Publicado: (2019)

The Impact of 9-Valent HPV Vaccination on Couple Infertility Prevention: A Comprehensive Review
por: Ciavattini, Andrea, et al.
Publicado: (2021)

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
por: Mahumud, Rashidul Alam, et al.
Publicado: (2020)

Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
por: Datta, Samik, et al.
Publicado: (2019)

HPV catch-up vaccination of young women: a systematic review and meta-analysis
por: Couto, Elisabeth, et al.
Publicado: (2014)

Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway
por: Van Boetzelaer, E., et al.
Publicado: (2021)

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
por: Marty, Rémi, et al.
Publicado: (2013)

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
por: Elbasha, Elamin H.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ot938g9tc4q3odjjgllemkjpbc